Overview

P.Vivax Treatment Trial

Status:
Completed

Trial end date:
2018-06-15

Target enrollment:

Participant gender:

Summary

This study aims to determine whether a 14 day course of 0.5 mg/kg/day primaquine can eliminate subclinical P. vivax infections detected by high volume ultra-sensitive PCR (uPCR).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Oxford

Collaborator:

Mahidol Oxford Tropical Medicine Research Unit

Treatments:

Artemisinins
Artenimol
Dihydroartemisinin
Piperaquine
Primaquine